Related references
Note: Only part of the references are listed.Successful treatment of pityriasis rubra pilaris with tildrakizumab
Samuel S. Zagarella et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2022)
Refractory Type I pityriasis rubra pilaris treated with tildrakizumab
G. Licata et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)
Biologics for pityriasis rubra pilaris treatment: A review of the literature
Monica Napolitano et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris
Laurence Feldmeyer et al.
JAMA DERMATOLOGY (2017)
Share Paper
